{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T11:29:11Z","timestamp":1767526151901,"version":"3.48.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,4]]},"DOI":"10.7759\/cureus.100726","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T11:27:22Z","timestamp":1767526042000},"source":"Crossref","is-referenced-by-count":0,"title":["Population Screening for Diabetes and Prediabetes in North Macedonia and Bosnia and Herzegovina: A Transnational Epidemiological Report"],"prefix":"10.7759","author":[{"given":"Tatjana","family":"Milenkovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zelija","family":"Velija Asimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivica","family":"Smokovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadica","family":"Bozhinovska Dimova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azra","family":"Burekovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"International Diabetes Federation. IDF Diabetes Atlas. 8th ed. (2017). Accessed. 6 July 2018: https:\/\/diabetesatlas.org\/resources\/previous-editions\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.07.015","article-title":"First stratified diabetes prevalence data for Republic of Macedonia derived from the National eHealth System","volume":"143","author":"Smokovski I","year":"2018","unstructured":"Smokovski I, Milenkovic T, Cho NH. First stratified diabetes prevalence data for Republic of Macedonia derived from the National eHealth System. Diabetes Res Clin Pract. 2018, 143:179-83. 10.1016\/j.diabres.2018.07.015","journal-title":"Diabetes Res Clin Pract"},{"key":"ref3","article-title":"IDF Diabetes Atlas. 10th ed","author":"Magliano DJ","year":"2021","unstructured":"Magliano DJ, Boyko EJ. IDF Diabetes Atlas. 10th ed. International Diabetes Federation, Brussels; 2021."},{"key":"ref4","unstructured":"Health status of the population and health care in the FBiH [In Bosnian]. (2017). Accessed. 2 January 2026: http:\/\/www.zzjzfbih.ba\/zdravstvena-stanja-stanovnistva\/2017."},{"key":"ref5","unstructured":"Public Health Institute of the Republic of Srpska [In Bosnian]. (2017). Accessed. 2 January 2026: https:\/\/www.phi.rs.ba\/index.php?lang=SR-CIR."},{"key":"ref6","unstructured":"Federal Plant for Statistics, Bosnia and Herzegovina [In Bosnian]. (n.d). Accessed. 2 January 2026: https:\/\/fzs.ba\/."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2021.05.002","article-title":"Screening for diabetes and prediabetes","volume":"50","author":"Duan D","year":"2021","unstructured":"Duan D, Kengne AP, Echouffo-Tcheugui JB. Screening for diabetes and prediabetes. Endocrinol Metab Clin North Am. 2021, 50:369-85. 10.1016\/j.ecl.2021.05.002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7326\/M15-2345","article-title":"Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force Recommendation Statement","volume":"163","author":"Siu AL","year":"2015","unstructured":"Siu AL. Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2015, 163:861-8. 10.7326\/M15-2345","journal-title":"Ann Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-01338","article-title":"Primary prevention of ASCVD and T2DM in patients at metabolic risk: an Endocrine Society* Clinical Practice Guideline","volume":"104","author":"Rosenzweig JL","year":"2019","unstructured":"Rosenzweig JL, Bakris GL, Berglund LF, et al.. Primary prevention of ASCVD and T2DM in patients at metabolic risk: an Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab. 2019, 104:3939-85. 10.1210\/jc.2019-01338","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00291-0","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study","volume":"3","author":"Diabetes Prevention Program Research Group","year":"2015","unstructured":"Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015, 3:866-75. 10.1016\/S2213-8587(15)00291-0","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2014.01.008","article-title":"How diabetes risk assessment tools are implemented in practice: a systematic review","volume":"104","author":"Dhippayom T","year":"2014","unstructured":"Dhippayom T, Chaiyakunapruk N, Krass I. How diabetes risk assessment tools are implemented in practice: a systematic review. Diabetes Res Clin Pract. 2014, 104:329-42. 10.1016\/j.diabres.2014.01.008","journal-title":"Diabetes Res Clin Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4158\/EP15866.OR","article-title":"Opportunistic screening for diabetes and prediabetes using hemoglobin A1c in an urban primary care setting","volume":"22","author":"Sohler N","year":"2016","unstructured":"Sohler N, Matti-Orozco B, Young E, et al.. Opportunistic screening for diabetes and prediabetes using hemoglobin A1c in an urban primary care setting. Endocr Pract. 2016, 22:143-50. 10.4158\/EP15866.OR","journal-title":"Endocr Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.12531","article-title":"Screening for prediabetes and type 2 diabetes. US Preventive Services Task Force Recommendation Statement","volume":"326","author":"Davidson KW","year":"2021","unstructured":"Davidson KW, Barry MJ, Mangione CM, et al.. Screening for prediabetes and type 2 diabetes. US Preventive Services Task Force Recommendation Statement. JAMA. 2021, 326:736-43. 10.1001\/jama.2021.12531","journal-title":"JAMA"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/437568-population-screening-for-diabetes-and-prediabetes-in-north-macedonia-and-bosnia-and-herzegovina-a-transnational-epidemiological-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T11:27:23Z","timestamp":1767526043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/437568-population-screening-for-diabetes-and-prediabetes-in-north-macedonia-and-bosnia-and-herzegovina-a-transnational-epidemiological-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,4]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.100726","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,4]]}}}